The Associated Press authored a story today on MedPage Today about seasonal affective disorder, including its subtypes, potential causes, and possible treatments. Read the story here.
Blood glucose can surge within the first three months of treatment in those who start taking an oral second-generation neuroleptic. A study looked at both weight gain and HbA1c measurements and found that the two don’t necessarily change at the same rate. Early monitoring of both may help identify risk sooner and support timely intervention, according to the study’s lead researcher. Read the story about the study here and the summary of the research in The Lancet here.
One psychiatrist asks if we’re overdiagnosing human suffering and asks how professionals can be more mindful about what they expect a diagnosis to do. Read the story here.
Can metformin and semaglutide help with weight gain from neuroleptics in those living with schizophrenia? A recent systemic review and meta-analysis incidates they can, with a higher level of certainty than other interventions used in the study. Read the story here and read the summary of the research here.
A case report is one of several that suggest GLP-1s could interact with lithium. The subject of the case report experienced an increase in her serum lithium level from 0.7 to 1.2mmol/L and showed signs of lithium toxicity that resolved with a lowered dose of lithium. The increase occurred within three weeks of starting the GLP-1. Jorge Almeida, MD, PhD, recommends early monitoring in these situations to avoid complications. Read the story here and read the case report here.
Note: Greater Zion Support Alliance provides education around health and wellness as part of its mission. Everything we share is informational. Discuss any changes you might want to incorporate with your provider.
Leave a Reply